Law firm Cyril Amarchand Mangaldas assists with Godrej Astec LifeSciences' ₹238 crore share offering
Cyril Amarchand Mangaldas Advises Godrej Astec LifeSciences on ₹238.2 Crore Rights Issue
Godrej Astec LifeSciences, a subsidiary of Godrej Agrovet, has received legal advice for their ₹238.2 crore (INR 2,382 million) rights issue of equity shares from the law firm Cyril Amarchand Mangaldas. The key team members from Cyril Amarchand Mangaldas who led this advisory were Yash Ashar and Devaki Mankad.
Godrej Astec LifeSciences is a prominent player in the production of agrochemicals, with over 150 reactors in operation. The company manufactures and distributes a wide variety of agrochemical active ingredients and pharmaceutical intermediates. They are significant players in the production of Triazole Fungicides, Herbicides, and Insecticides.
The company's operations cover the manufacturing and distribution of agrochemicals and pharmaceuticals. They operate from nine manufacturing units and have an extensive infrastructure. In addition to their agrochemical products, Godrej Astec LifeSciences also produces a range of intermediates for the pharmaceutical sector.
The transaction was led by Yash J. Ashar (Senior Partner), Devaki Mankad (Partner, Regional Co-Head - Capital Markets - West), and Abhyuday Bhotika (Partner). Veena Raghav (Senior Associate Designate), Anna Kallivayalil (Associate), and Mahima Aggarwal (Associate) provided support in the transaction.
[1] Source: Cyril Amarchand Mangaldas Press Release, dated 27th May 2021.
Read also:
- German Obsession with Luxury Vehicles Thriving Amid Traffic Congestion
- Ferrero, Nudossi, and other manufacturers face potential price hikes for Nutella due to an upcoming hazelnut crisis, and here's how they plan to react.
- Coastal men's disruptions of dolphin gatherings might lead to jail sentences
- Electric car from Lucid unseats Chevrolet Corvette Z06 in awe-inspiring speed test performance.
